National HealthCare Yönetim

Yönetim kriter kontrolleri 3/4

National HealthCare CEO'su Steve Flatt, Jan2017 tarihinde atandı, in görev süresi 7.92 yıldır. in toplam yıllık tazminatı $ 1.61M olup, şirket hissesi ve opsiyonları dahil olmak üzere 32.8% maaş ve 67.2% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.37% ine doğrudan sahiptir ve bu hisseler $ 6.25M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 7.8 yıl ve 20.7 yıldır.

Anahtar bilgiler

Steve Flatt

İcra Kurulu Başkanı

US$1.6m

Toplam tazminat

CEO maaş yüzdesi	32.8%
CEO görev süresi	7.9yrs
CEO sahipliği	0.4%
Yönetim ortalama görev süresi	7.8yrs
Yönetim Kurulu ortalama görev süresi	20.7yrs

Son yönetim güncellemeleri

Recent updates

Why We Think National HealthCare Corporation's (NYSEMKT:NHC) CEO Compensation Is Not Excessive At All

May 01

Returns On Capital At National HealthCare (NYSEMKT:NHC) Paint A Concerning Picture

Apr 09

Is National HealthCare Corporation (NYSEMKT:NHC) A Good Fit For Your Dividend Portfolio?

Mar 17

National HealthCare Corporation's (NYSEMKT:NHC) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?

Mar 02

National HealthCare Corporation (NYSEMKT:NHC) Insiders Have Been Selling

Feb 15

Reflecting on National HealthCare's (NYSEMKT:NHC) Share Price Returns Over The Last Year

Feb 02

Could The National HealthCare Corporation (NYSEMKT:NHC) Ownership Structure Tell Us Something Useful?

Jan 20

These Metrics Don't Make National HealthCare (NYSEMKT:NHC) Look Too Strong

Jan 07

Do These 3 Checks Before Buying National HealthCare Corporation (NYSEMKT:NHC) For Its Upcoming Dividend

Dec 25

What We Learned About National HealthCare's (NYSEMKT:NHC) CEO Pay

Dec 24

Is National HealthCare Corporation's (NYSEMKT:NHC) 3.1% Dividend Worth Your Time?

Dec 12

Does National HealthCare Corporation's (NYSEMKT:NHC) Weak Fundamentals Mean A Downturn In Its Stock Should Be Expected?

Nov 30

CEO Tazminat Analizi

Steve Flatt'un ücretlendirmesi National HealthCare'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	US$124m
Jun 30 2024	n/a	n/a	US$92m
Mar 31 2024	n/a	n/a	US$81m
Dec 31 2023	US$2m	US$528k	US$67m
Sep 30 2023	n/a	n/a	US$45m
Jun 30 2023	n/a	n/a	US$32m
Mar 31 2023	n/a	n/a	US$19m
Dec 31 2022	US$1m	US$522k	US$22m
Sep 30 2022	n/a	n/a	US$32m
Jun 30 2022	n/a	n/a	US$31m
Mar 31 2022	n/a	n/a	US$133m
Dec 31 2021	US$2m	US$498k	US$139m
Sep 30 2021	n/a	n/a	US$150m
Jun 30 2021	n/a	n/a	US$167m
Mar 31 2021	n/a	n/a	US$90m
Dec 31 2020	US$1m	US$476k	US$42m
Sep 30 2020	n/a	n/a	US$28m
Jun 30 2020	n/a	n/a	US$35m
Mar 31 2020	n/a	n/a	US$20m
Dec 31 2019	US$1m	US$495k	US$68m
Sep 30 2019	n/a	n/a	US$73m
Jun 30 2019	n/a	n/a	US$74m
Mar 31 2019	n/a	n/a	US$83m
Dec 31 2018	US$1m	US$393k	US$59m
Sep 30 2018	n/a	n/a	US$62m
Jun 30 2018	n/a	n/a	US$52m
Mar 31 2018	n/a	n/a	US$41m
Dec 31 2017	US$1m	US$145k	US$56m

Tazminat ve Piyasa: Steve 'nin toplam tazminatı ($USD 1.61M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 5.47M ).

Tazminat ve Kazançlar: Steve 'in maaşı son bir yılda %20'den fazla arttı.

CEO

Steve Flatt (68 yo)

7.9yrs

Görev süresi

US$1,609,695

Tazminat

Dr. Stephen F. Flatt, also known as Steve, has been the Chief Executive Officer of National HealthCare Corporation since January 1, 2017. Dr. Flatt served as the President of National Healthcare Corporatio...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Stephen Flatt	CEO & Director	7.9yrs	US$1.61m	0.37% $ 6.3m
R. Ussery	President & COO	15.9yrs	US$1.49m	1.0% $ 16.9m
Brian Kidd	Senior VP & CFO	no data	US$815.48k	0.14% $ 2.4m
B. Flatt	Senior VP & Chief Information Officer	7.8yrs	US$767.33k	0.078% $ 1.3m
Josh McCreary	Senior VP	5.7yrs	US$813.94k	0.043% $ 735.6k
Carl Adams	Founder	no data	Veri yok	Veri yok
Vicki Dodson	Senior Vice President of Patient Services	5.5yrs	Veri yok	0.045% $ 763.2k
Timothy Shelly	Senior Vice President of Operations	no data	Veri yok	0.0040% $ 67.4k

7.8yrs

Ortalama Görev Süresi

62yo

Ortalama Yaş

Deneyimli Yönetim: NHC 'un yönetim ekibi deneyimli ve deneyimlidir ( 7.8 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Stephen Flatt	CEO & Director	7.9yrs	US$1.61m	0.37% $ 6.3m
W. Adams	Independent Director	50.9yrs	US$189.88k	4.52% $ 76.4m
Robert Adams	Independent Chairman	15.9yrs	US$192.88k	2.85% $ 48.2m
Richard LaRoche	Independent Director	22.9yrs	US$204.88k	2.3% $ 38.9m
Emil Hassan	Independent Director	20.7yrs	US$196.88k	0.47% $ 8.0m
James Abernathy	Independent Director	21.9yrs	US$196.88k	0.22% $ 3.6m
Sandra Trail	Independent Director	2.8yrs	US$192.88k	0.036% $ 615.4k

20.7yrs

Ortalama Görev Süresi

77yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: NHC 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 20.7 yıldır).

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2024/12/30 16:42
Gün Sonu Hisse Fiyatı	2024/12/30 00:00
Kazançlar	2024/09/30
Yıllık Kazançlar	2023/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Buradan daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları 'da mevcuttur.

Analist Kaynakları

National HealthCare Corporation 2 Bu analistlerden 0, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Robert Mains	Morgan Keegan & Company
Jayaprabha Dhavale	Virtua Research Inc.

National HealthCare Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

National HealthCare Corporation, Annual General Meeting, May 08, 2025

Senior VP & CFO recently sold US$260k worth of stock

CEO & Director recently sold US$494k worth of stock

Independent Chairman exercised options to buy US$389k worth of stock.

Independent Director exercised options to buy US$420k worth of stock.

National HealthCare Corporation, Annual General Meeting, May 09, 2024

Recent updates

Upcoming dividend of US$0.61 per share

National HealthCare Corporation, Annual General Meeting, May 08, 2025

Third quarter dividend of US$0.61 announced

Third quarter 2024 earnings released: EPS: US$2.78 (vs US$0.68 in 3Q 2023)

National HealthCare Corporation Announces Quarterly Dividend, Payable on January 31, 2025

Upcoming dividend of US$0.61 per share

Senior VP & CFO recently sold US$260k worth of stock

CEO & Director recently sold US$494k worth of stock

Independent Chairman exercised options to buy US$389k worth of stock.

Second quarter dividend of US$0.61 announced

Second quarter 2024 earnings released: EPS: US$1.74 (vs US$1.06 in 2Q 2023)

National Healthcare Corporation Announces Quarterly Dividend, Payable on November 1, 2024

Upcoming dividend of US$0.61 per share

First quarter dividend increased to US$0.61

National Healthcare Corporation Declares Quarterly Dividend, Payable on August 1, 2024

First quarter 2024 earnings released: EPS: US$1.71 (vs US$0.76 in 1Q 2023)

Independent Director exercised options to buy US$420k worth of stock.

National HealthCare Corporation, Annual General Meeting, May 09, 2024

Upcoming dividend of US$0.59 per share

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: US$4.36 (vs US$1.46 in FY 2022)

Third quarter dividend of US$0.59 announced

NHC Announces Quarterly Common Dividend, Payable on May 1, 2024

Independent Director exercised options to buy US$312k worth of stock.

Upcoming dividend of US$0.59 per share at 2.5% yield

Independent Chairman exercised options to buy US$290k worth of stock.

Independent Director recently sold US$641k worth of stock

Third quarter 2023 earnings released: EPS: US$0.68 (vs US$0.16 loss in 3Q 2022)

National Healthcare Corporation Announces Quarterly Dividend, Payable on February 1, 2024

Independent Director exercised options to buy US$131k worth of stock.

Upcoming dividend of US$0.59 per share at 3.5% yield

Independent Chairman recently bought US$131k worth of stock

New major risk - Revenue and earnings growth

Second quarter 2023 earnings released: EPS: US$1.06 (vs US$0.21 in 2Q 2022)

National Healthcare Corporation Announces Quarterly Dividend, Payable on November 1, 2023

Independent Director recently bought US$129k worth of stock

Upcoming dividend of US$0.59 per share at 3.9% yield

Independent Director recently bought US$135k worth of stock

National HealthCare Corporation Announces Quarterly Dividend, Payable on July 31, 2023

First quarter 2023 earnings released: EPS: US$0.76 (vs US$0.99 in 1Q 2022)

Upcoming dividend of US$0.57 per share at 4.1% yield

Independent Director recently bought US$125k worth of stock

Full year 2022 earnings released: EPS: US$1.46 (vs US$9.03 in FY 2021)

National Healthcare Corporation Declares Quarterly Dividend, Payable on May 1, 2023

Upcoming dividend of US$0.57 per share

Independent Director exercised options to buy US$106k worth of stock.

Independent Director recently sold US$211k worth of stock

Insufficient new directors

National HealthCare Corporation Announces Quarterly Dividend, Payable on February 1, 2023

Third quarter 2022 earnings released: US$0.16 loss per share (vs US$0.22 loss in 3Q 2021)

Upcoming dividend of US$0.57 per share

Independent Director exercised options to buy US$175k worth of stock.

National HealthCare Corporation (NYSEAM:NHC) announces an Equity Buyback for $25 million worth of its shares.

Second quarter 2022 earnings released: EPS: US$0.21 (vs US$6.83 in 2Q 2021)

National Healthcare Corporation Announces Quarterly Dividend, Payable on November 1, 2022

Upcoming dividend of US$0.57 per share

Independent Chairman exercised options to buy US$135k worth of stock.

Independent Director exercised options to buy US$529k worth of stock.

First quarter 2022 earnings released: EPS: US$0.99 (vs US$1.39 in 1Q 2021)

National Healthcare Corporation Announces Quarterly Dividend, Payable on August 1, 2022

Insufficient new directors

Upcoming dividend of US$0.55 per share

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

National Healthcare Corporation Announces Quarterly Dividend, Payable on May 2, 2022

National HealthCare Corporation Appoints Sandra Y. Trail to Its Board of Director, Effective February 1, 2022

Independent Director exercised options to buy US$350k worth of stock.

Upcoming dividend of US$0.55 per share

CEO & Director exercised options and sold US$132k worth of stock

Third quarter 2021 earnings released: US$0.22 loss per share (vs US$0.84 profit in 3Q 2020)